Projecting vaccine efficacy: Accounting for geographic strain variations

PharmacoEconomics

Volumn 26, Issue 3, 2008, Pages 185-189

  Rose, Johnie ^a   Singer, Mendel E ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cost effectiveness; Modelling; Rotavirus infections, prevention; Rotavirus vaccine, therapeutic use; Vaccines, therapeutic use

Indexed keywords

LIVE VACCINE; ROTAVIRUS VACCINE; VACCINE;

CLINICAL TRIAL; DRUG EFFICACY; DRUG EFFICACY PROJECTION; HUMAN; IMMUNIZATION; INDIA; PRIORITY JOURNAL; REVIEW; ROTAVIRUS; STRAIN DIFFERENCE; VALIDATION PROCESS; VIRUS INFECTION; VIRUS STRAIN;

EID: 39449111289     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200826030-00003     Document Type: Review

References (16)

1. Glass R, Parashar U, Bresee J, et al. Rotavirus vaccines: current prospects and future challenges. Lancet 2006 Jul 22; 368: 323-32
2. Salinas B, Perez Schael I, Linhares AC, et al. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: a randomized, placebo-controlled trial in Latin American infants. Pediatr Infect Dis J 2005 Sep; 24 (9): 807-16
3. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006 Jan 5; 354 (1): 11-22
4. Vesikari T, Karvonen A, Puustinen L, et al. Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants. Pediatr Infect Dis J 2004 Oct; 23 (10): 937-43
5. Parashar UD, Glass RI. Public health: progress toward rotavirus vaccines. Science 2006 May 12; 312 (5775): 851-2
6. Glass RI, Bresee JS, Turcios R, et al. Rotavirus vaccines: targeting the developing world. J Infect Dis 2005 Sep 1; 192 Suppl. 1: S160-6
7. Santos N, Hoshino Y. Global distribution of rotavirus serotypes/ genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005 Jan-Feb; 15 (1): 29-56
8. Fischer TK, Anh DD, Antil L, et al. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam. J Infect Dis 2005 Nov 15; 192 (10): 1720-6
9. Podewils LJ, Antil L, Hummelman E, et al. Projected cost-effectiveness of rotavirus vaccination for children in Asia. J Infect Dis 2005 Sep 1; 192 Suppl. 1: S133-45
10. Rose J, Molnar R, Watts B, et al. Cost-effectiveness of a rotavirus vaccination program in India [poster presentation]. Society for Medical Decision Making Annual Meeting; 2006 Oct 15; Cambridge (MA) [online]. Available at URL: http://smdm.confex.com/smdm/2006ma/techprogram/p3094.htm [Accessed 2008 Feb 2]
11. Jain V, Das BK, Bhan MK, et al. Great diversity of group A rotavirus strains and high prevalence of mixed rotavirus infections in India. J Clin Microbiol 2001 Oct; 39 (10): 3524-9
12. Jit M, Edmunds WJ. Evaluating rotavirus vaccination in England and Wales: part II. The potential cost-effectiveness of vaccination. Vaccine 2007 May 16; 25 (20): 3971-9
13. Bilcke J, Beutels P, De Smet F, et al. Cost-effectiveness analysis of rotavirus vaccination of Belgian infants [KCE reports; 54C]. Belgian Health Care Knowledge Centre; 2007 [online]. Available from URL: http://kce.fgov.be/ index_en.aspx?ID=0&SGREF=9152&CREF=9409 [Accessed 2008 Feb 8]
14. Centers for Disease Control. Update: global rotavirus laboratory network. Rotavirus Surveillance News 2006; 1 (4): 1-2
15. Jaffe S. New rotavirus vaccines on the horizon. Scientist 2005; 19 (3): 37-9
16. Araujo EC, Clemens SA, Oliveira CS, et al. Safety, immunogenicity, and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy infants. J Pediatr (Rio J) 2007 May-Jun; 83 (3): 217-24